<p>Generally speaking, while NMIBCs have a more favourable prognosis compared to their MI counterpart, they are not the same and seem to behave differently (i.e. some are relatively indolent, others have aggressive features). In this episode, Prof. Paolo Gontero explains why. He will also discuss the following:</p><ul><li>What is the current, best-recommended way for risk stratification of NMIBCs</li><li>If there is a way to predict the risk of recurrence of a NMIBC</li><li>How to tailor treatment recommendations</li></ul><p>Guest: Prof. Paolo Gontero, member of the EAU Guidelines panel for Non-Muscle Invasive Bladder Cancer </p>

Why should we make a podcast?

This is the official podcast channel of the European Association of Urology and the European School of Urology. The EAU Podcast is your source for the latest information across the full urological spectrum. Take your clinical practice to new heights and tune in!